Biotech Startups

KHAN is a drug discovery investment company that finances and translates early-stage academic science into pharmaceutical products, retaining IP rights on the projects it funds. It works in close partnership with the Lead Discovery Center in Dortmund and Munich and co-invests with the Max Planck Society in drug discovery projects from Max Planck Institutes.

1 investor

InformDx (Inform Diagnostics) provides subspecialty anatomic pathology laboratory services, working directly with clinicians to deliver diagnostic testing and results for patient diagnoses. Its offerings cover gastrointestinal pathology, dermatopathology, urologic pathology, hematopathology, breast pathology, and COVID-19 testing, primarily serving physicians and medical practices in the United States.

1 investor

InformedDNA applies genetics expertise and technology to deliver genomics insights and services such as telegenetic counseling for payors, healthcare providers, and patients across the US. It operates in the digital health and genomics space, supporting clinical decisions around screening, diagnosis, and treatment.

1 investor

Informuta provides predictive infection intelligence tools that forecast antibiotic resistance risk to help clinicians prevent treatment failures and optimize antibiotic prescribing decisions. The company serves healthcare providers and infectious disease practitioners with AI-driven diagnostics and bacterial evolutionary analytics.

1 investor

InfuSense develops an electrochemical sensing technology platform that detects analytes at sub-therapeutic levels, delivering sample analysis results within minutes. The portable device is designed to bring laboratory-scale testing capabilities into a handheld form factor.

1 investor

IngateyGen develops peanut varieties engineered for improved safety and nutritional value, aiming to reduce the risk of peanut allergies. The company partners with the food value chain to bring these products to market for consumers, particularly families concerned about allergic reactions.

1 investor

Ingelia develops biochar and related bioproducts from waste through hydrothermal carbonization (HTC) technology, serving agricultural, energy, and industrial sectors. The company produces biochar for soil conditioning, bioenergy fuels, bio-coke for steel production, and other specialized bioproducts with reduced carbon emissions.

1 investor

InGeno develops personalized genetic tests based on DNA analysis, providing individuals with information about their predispositions related to nutrition, sports, health, skin, and hair. Customers order a test online, receive a home collection kit, and get a report with the option to consult an expert.

1 investor

IngredientWerks is a molecular farming company that engineers plants to produce plant-based proteins and ingredients for the alternative protein market. It develops these ingredients as substitutes for conventional proteins, targeting food and nutrition applications.

1 investor

Inhalis Therapeutics researches and develops inhaled treatments for Idiopathic Pulmonary Fibrosis and other life-threatening diseases, using inhalation delivery technology. It focuses on providing safer and more effective therapy options for patients.

1 investor

INHERET provides an online tool that collects detailed family health histories and evaluates hereditary cancer risk, then links to best-practice guidelines so providers can recommend next steps. It serves individuals and healthcare providers to identify, understand, and manage risks of hereditary conditions such as colon, breast, ovarian, pancreatic, and prostate cancers.

1 investor

Inimmune is a clinical-stage biotech company developing immunotherapies for allergy, cancer, infectious, and autoimmune diseases. The company combines immunology and vaccine expertise to advance its clinical and pre-clinical pipeline.

1 investor

Inka's Berries develops new blueberry varieties and produces fresh blueberries for export through two business divisions focused on genetic innovation and cultivation. The company operates in Peru with operations spanning genetic research, farming, packing, and international distribution.

1 investor

INKE develops and manufactures active pharmaceutical ingredients (APIs), including high-potency APIs and ophthalmic solutions, using chemical synthesis and micronization technologies. It operates two cGMP manufacturing sites with capabilities in crystal engineering, chromatographic purification, and high-containment handling.

1 investor

InkVivo Technologies develops polymer-based drug delivery platforms (GARD/gastroretentive and SHEALD/injectable) for controlled, localized, and sustained release of small molecules and biologics. An ETH Zurich spin-off, it works with pharmaceutical and nutraceutical partners to improve bioavailability and patient adherence, with programs targeting iron deficiency anemia and neurodegenerative diseases.

1 investor

Inmedix is a medical research and diagnostics company that originated as a patent holding firm for discoveries related to treatments such as using dopamine agonists for fibromyalgia, and later shifted to precision diagnostics aimed at understanding why patients respond differently to the same treatment. It operates in the healthcare and diagnostics field.

1 investor

The Laboratory of Immuno-Regulation (LIR) is a research group at the Gregorio Marañón Hospital Health Research Institute in Madrid that studies regulatory T cells and thymic tissue for treating autoimmune diseases and transplant rejection. Its work includes cell-based therapies and has led to a biotech spin-off, Thytech.

1 investor

InnAccel Technologies develops advanced medical devices and intelligent healthcare solutions using a structured biodesign methodology to address clinical unmet needs in critical care and maternal health settings.

1 investor

1 investor

Innervate is a radiopharmaceutical company focused on drug development, manufacturing, and clinical trials in the nuclear medicine and medical imaging space. Its leadership team draws on experience from radiopharmaceutical and pharmaceutical companies such as Navidea, Lantheus, and GE Healthcare.

1 investor

Innolact develops biodegradable biopolymers from whey permeate and urban sludge for food packaging applications. The company operates a pilot production plant converting waste streams into polyhydroxyalkanoate (PHA) materials as a sustainable packaging alternative.

1 investor

Innomy Labs develops sustainable protein sources from mycelium (fungi) as alternatives to plant and animal proteins, and offers customized R&D services to food-industry partners for fungi-based protein production and by-product valorization. It focuses on improving the food system through circular-economy and sustainable food production methods.

1 investor

A drug discovery platform that combines protein chip technology with AI to accelerate the development of new pharmaceuticals.

1 investor

Innophore builds Catalophore, a point-cloud technology that maps protein binding sites as multidimensional fingerprints to search across proteomes by the shape and chemistry of active sites. It offers software tools and computational discovery services for pharma and biotechnology, covering enzyme discovery, drug repurposing, off-target safety screening and protein engineering.

1 investor